Overview
Fabrizio Simeoni practices in Manchester, United Kingdom. Mr. Simeoni is rated as an Advanced expert by MediFind in the treatment of RUNX1 Familial Platelet Disorder. His top areas of expertise are RUNX1 Familial Platelet Disorder, Triple-Negative Breast Cancer, Acute Myeloid Leukemia (AML), and Leukemia.
His clinical research consists of co-authoring 11 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of RUNX1 Familial Platelet Disorder.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- RUNX1 Familial Platelet DisorderMr. Simeoni isAdvanced. Learn about RUNX1 Familial Platelet Disorder.
- Experienced
- Acute Myeloid Leukemia (AML)Mr. Simeoni isExperienced. Learn about Acute Myeloid Leukemia (AML).
- LeukemiaMr. Simeoni isExperienced. Learn about Leukemia.
- Triple-Negative Breast CancerMr. Simeoni isExperienced. Learn about Triple-Negative Breast Cancer.